New speech therapy shows promise for kids with apraxia
NCT ID NCT03903120
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a speech therapy called ASSIST for children aged 4 to 9 with childhood apraxia of speech, a disorder that makes it hard to plan speech movements. Fifty-one children received 16 hours of individual therapy using repetition and cues. The goal was to see if the therapy improves speech accuracy and everyday communication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ASSIST (a behavioral speech therapy using repetition and cues)
What this could lead to
If successful, this could point toward a more effective therapy for children with apraxia of speech, improving their ability to speak clearly.
What could go wrong
This is an early Phase 1 study with only 51 children, so results may not apply to all. The therapy is intensive and may not work for every child.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD APRAXIA OF SPEECH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Temple University
Philadelphia, Pennsylvania, 19122, United States